Cargando…

Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?

Detalles Bibliográficos
Autores principales:	Afra, TP, T, Muhammed Razmi, Bishnoi, Anuradha, Hafi, NA Bishurul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832625/ https://www.ncbi.nlm.nih.gov/pubmed/32559452 http://dx.doi.org/10.1016/S1473-3099(20)30472-2

Ejemplares similares

Linking hydroxychloroquine to hemolysis in a ‘suspected’ glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection – a critical appraisal
por: Afra, T.P., et al.
Publicado: (2020)

Comorbid psoriasis-bipolar disorder successfully treated with apremilast: much more than a mere coincidence?
por: Uvais, N A, et al.
Publicado: (2020)

Palliative Dermatology
por: Bishurul Hafi, NA, et al.
Publicado: (2018)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Hydroxychloroquine prophylaxis for COVID-19 contacts in India
por: Rathi, Sahaj, et al.
Publicado: (2020)

Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
por: Alizargar, Javad
Publicado: (2020)

Hydroxychloroquine and COVID-19: a tale of populism and obscurantism
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Hydroxychloroquine for chemoprophylaxis in COVID-19: A case of motivated perception?
por: Manjunath, B.G., et al.
Publicado: (2020)

Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
por: Pareek, Anil, et al.
Publicado: (2020)

Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
por: Honoré, Stéphane, et al.
Publicado: (2021)

Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients?
por: Ayerbe, Luis, et al.
Publicado: (2021)

Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”
por: Bonny, Aimé, et al.
Publicado: (2020)

Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians
por: Schreiber, Karen, et al.
Publicado: (2020)

Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach
por: Tilangi, Praveen, et al.
Publicado: (2020)

Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence
por: Furlan, Leonardo
Publicado: (2022)

Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? – Authors' reply
por: Rentsch, Christopher T, et al.
Publicado: (2021)

Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
por: Kaur, Hardeep, et al.
Publicado: (2021)

Atrophic Hyperpigmented Lesions Over Trunk in a Middle-Aged Female
por: Sharma, Apoorva, et al.
Publicado: (2023)

Apremilast in Psoriasis and Beyond: Big Hopes on a Small Molecule
por: Afra, T. P., et al.
Publicado: (2019)

Reversible Melanonychia Revealing Nutritional Vitamin-B12 Deficiency
por: Afra, T. P., et al.
Publicado: (2020)

Unilateral Heliotrope Rash, Inverse Gottron's Papules and Anti-MDA5 Antibody Positivity: A Triad Suggesting Lung Involvement
por: Bhandari, Adhyatm, et al.
Publicado: (2022)

Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence
por: Bigna, Jean Joel, et al.
Publicado: (2020)

Clinical Spectrum of Autoerythrocyte Sensitization Syndrome: A Series of Five Cases
por: Thokchom, Nandakishore Singh, et al.
Publicado: (2018)

Dermoscopy as a Tool to Differentiate Reactive Arthritis from Psoriatic Arthritis
por: Razmi, Muhammed T., et al.
Publicado: (2022)

Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2
por: Neves, Fabricio Souza
Publicado: (2020)

Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19
por: Mazzitelli, Maria, et al.
Publicado: (2020)

Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention
por: Tarek, Mohammad, et al.
Publicado: (2020)

Side effects of hydroxychloroquine prophylaxis against COVID-19 in healthcare workers
por: Dixit, Prashant Kumar, et al.
Publicado: (2021)

The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vagina
por: Vermeer, H. A. B., et al.
Publicado: (2021)

Prophylactic use of hydroxychloroquine among healthcare workers in a case-control study
por: Kunte, Renuka, et al.
Publicado: (2020)

Skin Changes during Pregnancy: A Study from Northeast India
por: Dabette, Kharkongor Larisa, et al.
Publicado: (2018)

Interpreting the impact of hydroxychloroquine prophylaxis on SARS-CoV-2 infection
por: Yadav, Reetika Malik, et al.
Publicado: (2021)

Crizotinib-Induced Severe Photosensitive Dermatitis in a Carcinoma Lung Patient
por: Afra, T. P., et al.
Publicado: (2020)

SARS, MERS, and COVID-19: What's next?
por: Sharun, Khan
Publicado: (2020)

What comes next in the COVID-19 pandemic?
por: Fisher, Dale, et al.
Publicado: (2022)

COVID-19… What are drugs and strategies now?
por: Bellini, Valentina, et al.
Publicado: (2021)

Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19: What Is Known?
por: Shankar, Pathiyil Ravi, et al.
Publicado: (2021)

Extensive Discoid Lupus Erythematosus in a HIV patient Responding to Hydroxychloroquine Monotherapy
por: Bhagwat, Pradeep Vittal, et al.
Publicado: (2012)

Hydroxychloroquine-Induced Psoriasis-form Erythroderma in a Patient with Systemic Lupus Erythematosus
por: Wang, Wen-Ming, et al.
Publicado: (2018)

Hydroxychloroquine prophylaxis for SARS-CoV-2 infection among healthcare workers
por: Karim, Habib M.R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rnm7biaq68fi8nl65fbdejotqf